AUP Stock Price, Chart, Stats & News

Aurinia Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and marketing medical treatments. The company focuses on addressing various diseases across the United States and China. A key part of its pipeline involves voclosporin, an investigational compound being developed to treat conditions such as lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis.